Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

BudProfiles

The world's most comprehensive cannabis strain directory, backed by scientific research.

11,121 strains · 12,304 studies · 268 breeders

Treatment of COVID-19 olfactory dysfunction with olfactory t — 2023 Clinical Trial | BudProfiles

Home

Studies

Treatment of COVID-19 olfactory dysfunction with o...

PositiveClinical Trial2023

Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial

View Study View PDF

Classification Results

AI Classification

Positive

Fine-tuned Classification

Positive

Conditions Studied

COVID-19 Neurodegenerative Issues

Related Studies

Positive

Project Twenty21 Australia: A Case Study of the Treatment of Chronic Pelvic Pain Due To Endometriosis with Cannabidiol Oil

2025·Review/Other

Inconclusive

Cannabis use and mental health in adolescents’ brain development: a position paper

2025·Review/Other

Inconclusive

Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1G93 A) mouse model of amyotrophic lateral sclerosis

2025·Animal Study -

Inconclusive

Acute and subacute cardiovascular effects of synthetic cannabinoid JWH-018 in rat

2025·Review/Other

Positive

Ginsenoside RK1 inhibits microglial activation and ROS production and alleviates vascular dementia in rats

2025·Animal Study -

Inconclusive

Utilizing ADMET Analysis and Molecular Docking to Elucidate the Neuroprotective Mechanisms of a Cannabis-Containing Herbal Remedy (Suk-Saiyasna) in Inhibiting Acetylcholinesterase

2025·Laboratory Study -

Cannabinoids

Palmitoylethanolamide (PEA)

Organ Systems

Respiratory System

Study Details

Type: Clinical Trial
Year: 2023
Study ID: #2023038